{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T17:51:29Z","timestamp":1785261089827,"version":"3.55.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Incidental gallbladder cancer (IGBC), diagnosed post-cholecystectomy for presumed benign disease, presents critical management dilemmas. This study aimed to identify preoperative and pathological risk factors for residual disease (RD) after curative-intent resection, evaluate the impact of liver resection extent on survival stratified by RD status, and define patient subgroups benefiting from adjuvant chemotherapy (ACT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A retrospective cohort study of 209 IGBC patients undergoing curative-intent resection at [Blinded for review] was analyzed. Survival was analyzed using the Kaplan\u2013Meier method with log-rank test. Prognostic factors were identified via univariate and multivariate Cox regression analyses. Factors associated with RD were assessed using logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      RD was present in 75 patients (35.9%) and was a strong independent predictor of worse recurrence-free survival (\n                      <jats:italic toggle=\"yes\">HR<\/jats:italic>\n                      : 2.810, 95%\n                      <jats:italic toggle=\"yes\">CI<\/jats:italic>\n                      : 1.843\u00a0~\u00a04.282,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and overall survival (\n                      <jats:italic toggle=\"yes\">HR<\/jats:italic>\n                      : 4.155, 95%\n                      <jats:italic toggle=\"yes\">CI<\/jats:italic>\n                      : 2.550\u00a0~\u00a06.769,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Independent risk factors for RD included CA19-9\u00a0&gt;\u00a039.0\u00a0U\/ml, open cholecystectomy, primary T2 stage, primary T3 stage, perineural invasion (PNI), microvascular invasion (MVI), and station 12c lymph nodes metastasis (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Among RD patients, segment IVB\/V resection significantly improved median RFS (42.0\n                      <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                      11.0\u00a0months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01) and OS (60.0\n                      <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                      22.0\u00a0months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05) compared to wedge resection, while no difference was observed in non-RD patients (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). ACT significantly improved median OS compared to non-ACT in RD patients (not reached\n                      <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                      20.0\u00a0months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01), with a non-significant trend toward improved median RFS (40.0\n                      <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                      11.0\u00a0months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05), but showed non-significant trends in non-RD patients (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>RD is a critical independent prognostic factor in IGBC, predicted by elevated CA19-9, open cholecystectomy, advanced T stage, PNI\/MVI, and station 12c lymph nodes metastasis. For RD patients, segment IVB\/V resection and ACT both significantly improve OS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000004103","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T08:00:34Z","timestamp":1764144034000},"page":"7390-7399","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Guiding clinical decisions in incidental gallbladder cancer residual disease risk, liver resection extent, and selecting patients for adjuvant chemotherapy survival benefit"],"prefix":"10.1097","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4180-3974","authenticated-orcid":false,"given":"Zhenqi","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2645-9808","authenticated-orcid":false,"given":"Zhimin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"R1-20260417","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer","volume":"8","author":"Roa","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260417","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.ijsu.2014.08.367","article-title":"Managing the incidentally detected gallbladder cancer: algorithms and controversies","volume":"12","author":"Cavallaro","year":"2014","journal-title":"Int J Surg"},{"key":"R3-20260417","doi-asserted-by":"crossref","first-page":"107035","DOI":"10.1016\/j.ejso.2023.107035","article-title":"Lessons learnt from 1300 consecutive gallbladder cancer surgeries: evolving role of peri operative chemotherapy in the treatment paradigm","volume":"49","author":"Patkar","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"R4-20260417","doi-asserted-by":"crossref","first-page":"32\u201345","DOI":"10.1002\/bjs.11035","article-title":"Systematic review of management of incidental gallbladder cancer after cholecystectomy","volume":"106","author":"S\u00f8reide","year":"2019","journal-title":"Br J Surg"},{"key":"R5-20260417","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12893-022-01869-5","article-title":"Residual cancer is a strong predictor of survival in T3 incidental gallbladder cancer","volume":"22","author":"You","year":"2022","journal-title":"BMC Surg"},{"key":"R6-20260417","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12029-025-01212-0","article-title":"Incidental gallbladder cancer: a comprehensive review","volume":"56","author":"Kumar","year":"2025","journal-title":"J Gastrointest Cancer"},{"key":"R8-20260417","doi-asserted-by":"crossref","first-page":"113\u201320","DOI":"10.14701\/ahbps.24-223","article-title":"Neoadjuvant treatment for incidental gallbladder cancer: a systematic review","volume":"29","author":"Varshney","year":"2025","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"R9-20260417","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11912-018-0664-3","article-title":"Updates on gallbladder cancer management","volume":"20","author":"Zaidi","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"R10-20260417","first-page":"679\u201386","article-title":"Pathologic and prognostic implications of incidental versus nonincidental gallbladder cancer: a 10-institution study from the United States extrahepatic biliary malignancy consortium","volume":"83","author":"Ethun","year":"2017","journal-title":"Am Surg"},{"key":"R11-20260417","first-page":"100081","article-title":"Revised strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of Artificial Intelligence","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R12-20260417","doi-asserted-by":"crossref","first-page":"2334\u201343","DOI":"10.1245\/s10434-017-5859-6","article-title":"Incidental gallbladder cancer: residual cancer discovered at oncologic extended resection determines outcome: a report from high- and low-incidence countries","volume":"24","author":"Vinuela","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R13-20260417","doi-asserted-by":"crossref","first-page":"1015\u201327","DOI":"10.1200\/JCO.18.02178","article-title":"Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline","volume":"37","author":"Shroff","year":"2019","journal-title":"J Clin Oncol"},{"key":"R14-20260417","doi-asserted-by":"crossref","first-page":"619\u201330","DOI":"10.1016\/j.soc.2019.06.005","article-title":"Gallbladder cancer: managing the incidental diagnosis","volume":"28","author":"Cherkassky","year":"2019","journal-title":"Surg Oncol Clin N Am"},{"key":"R15-20260417","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12957-020-1794-2","article-title":"Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer","volume":"18","author":"Ramos","year":"2020","journal-title":"World J Surg Oncol"},{"key":"R16-20260417","doi-asserted-by":"crossref","first-page":"416\u201329","DOI":"10.1016\/j.jamcollsurg.2014.01.069","article-title":"Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer","volume":"219","author":"Butte","year":"2014","journal-title":"J Am Coll Surg"},{"key":"R17-20260417","doi-asserted-by":"crossref","first-page":"139\u201344","DOI":"10.1097\/SLA.0000000000003325","article-title":"Adverse outcomes after bile spillage in incidental gallbladder cancers: a population-based study","volume":"273","author":"Horkoff","year":"2021","journal-title":"Ann Surg"},{"key":"R18-20260417","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12885-020-6610-4","article-title":"Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma: a phase III study","volume":"20","author":"Goetze","year":"2020","journal-title":"BMC Cancer"},{"key":"R19-20260417","doi-asserted-by":"crossref","first-page":"1478\u201387","DOI":"10.1007\/s11605-007-0309-6","article-title":"Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re resection","volume":"11","author":"Pawlik","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"R20-20260417","doi-asserted-by":"crossref","first-page":"620\u201325","DOI":"10.1002\/jso.21681","article-title":"Incidental gallbladder cancer: analysis of surgical findings and survival","volume":"102","author":"Butte","year":"2010","journal-title":"J Surg Oncol"},{"key":"R21-20260417","doi-asserted-by":"crossref","first-page":"1035\u201341","DOI":"10.1007\/s00268-009-9950-4","article-title":"Lymphatic invasion: an important prognostic factor for stages T1b\u2013T3 gallbladder cancer and an indication for additional radical resection of incidental gallbladder cancer","volume":"33","author":"Shibata","year":"2009","journal-title":"World J Surg"},{"key":"R22-20260417","doi-asserted-by":"crossref","first-page":"1072\u201378","DOI":"10.1097\/SLA.0b013e318269d680","article-title":"Improving the AJCC\/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade","volume":"257","author":"Overman","year":"2013","journal-title":"Ann Surg"},{"key":"R23-20260417","doi-asserted-by":"crossref","first-page":"605\u201311","DOI":"10.1111\/j.1477-2574.2011.00335.x","article-title":"The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy?","volume":"13","author":"Patel","year":"2011","journal-title":"HPB (Oxford)"},{"key":"R24-20260417","doi-asserted-by":"crossref","first-page":"514\u201322","DOI":"10.1111\/j.1477-2574.2012.00489.x","article-title":"Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi institution analysis","volume":"14","author":"Fisher","year":"2012","journal-title":"HPB (Oxford)"},{"key":"R25-20260417","first-page":"409\u201317","article-title":"Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma","volume":"36","author":"Chatterjee","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R26-20260417","doi-asserted-by":"crossref","first-page":"1415\u201321","DOI":"10.1002\/cncr.25620","article-title":"Perineural invasion in pT3N0 rectal cancer: the incidence and its prognostic effect","volume":"117","author":"Peng","year":"2011","journal-title":"Cancer"},{"key":"R27-20260417","doi-asserted-by":"crossref","first-page":"1054\u201356","DOI":"10.1001\/archsurg.1993.01420210118016","article-title":"Gallbladder cancer discovered during laparoscopic surgery: potential for iatrogenic tumor dissemination","volume":"128","author":"Fong","year":"1993","journal-title":"Arch Surg"},{"key":"R28-20260417","doi-asserted-by":"crossref","first-page":"2161\u201365","DOI":"10.1007\/s00268-009-0163-7","article-title":"Use of retrieval bags in incidental gallbladder cancer cases","volume":"33","author":"Goetze","year":"2009","journal-title":"World J Surg"},{"key":"R29-20260417","doi-asserted-by":"crossref","first-page":"43\u201351","DOI":"10.1007\/s11605-017-3507-x","article-title":"Extended lymphadenectomy is required for incidental gallbladder cancer independent of cystic duct lymph node status","volume":"22","author":"Vega","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"R30-20260417","first-page":"243\u201351","article-title":"Branch of biliary surgery, chinese surgical society; chinese committee of biliary surgeons. Guideline for the diagnosis and treatment of gallbladder carcinoma (2019 edition)","volume":"58","author":"Quan","year":"2020","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"R31-20260417","doi-asserted-by":"crossref","first-page":"1216\u201327","DOI":"10.1002\/bjs.11205","article-title":"Management of incidental gallbladder cancer in a national cohort","volume":"106","author":"Lundgren","year":"2019","journal-title":"Br J Surg"},{"key":"R32-20260417","doi-asserted-by":"crossref","first-page":"40\u201348","DOI":"10.1111\/j.1477-2574.2012.00559.x","article-title":"A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate?","volume":"15","author":"Hari","year":"2013","journal-title":"HPB (Oxford)"},{"key":"R33-20260417","doi-asserted-by":"crossref","first-page":"656\u201363","DOI":"10.1111\/j.1477-2574.2009.00108.x","article-title":"Radical resection for T1b gallbladder cancer: a decision analysis","volume":"11","author":"Abramson","year":"2009","journal-title":"HPB (Oxford)"},{"key":"R34-20260417","doi-asserted-by":"crossref","first-page":"1061\u201368","DOI":"10.1016\/j.ejso.2019.01.013","article-title":"Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator","volume":"45","author":"Vega","year":"2019","journal-title":"Eur J Surg Oncol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000004103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:05:14Z","timestamp":1776423914000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000004103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000004103","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"2025-08-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}